Last edition
News about "transformative medicines "
Sanofi Announces Euro 1 Billion Share Buyback Programme for 2026
R&D-driven biopharma major Sanofi to repurchase shares worth up to Euro 1 billion between February and December 2026, reinforcing its capital allocation strategy and long-term growth outlook.
Transformative Medicines | 04/02/2026 | By News Bureau
GSK and LTZ Collaborate to Advance Novel Myeloid Cell Engagers in Oncology
Leveraging LTZ’s novel immune-engager platform and GSK’s oncology expertise, the partnership aims to deliver potent, safer cancer therapies that can be administered in community settings, supporting GSK’s strategy to advance transformative medicines through cutting-edge technologies.
Transformative Medicines | 20/11/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy